Onco Flashcards
most common tumors first year of life
neuroblastoma nephroblastoma retinoblastoma rhabdomyosarcoma hepatoblastoma medulloblastoma
most common tumor in 2-5yrs old
embryonal tumors
leukemia
non hodgkin lymphoma
glioma
ALL risk factor
ionizing radiation
Down syndrome is associated with an estimated 10-20–fold increased risk
NF1, Bloom syndrome, ataxia-telangiectasia, and Langerhans cell histiocytosis
AML risk factor
Down syndrome and NF1
optic glioma risk factor
NF1
Hodgkin disease risk factor
ebv
burkitt lymphoma risk factor
ebv in africa
osteosarcoma risk factor
Li-Fraumeni syndrome and hereditary retinoblastoma
wilms tumor risk factor
Aniridia (WAGR)
Beckwith-Wiedemann syndrome
rhabdomyosarcoma
Li-Fraumeni syndrome and NF1
hepatoblastoma risk factor
Beckwith-Wiedemann syndrome, hemihypertrophy, Gardner syndrome, and family
history of adenomatous polyposis
leiomyosarcoma risk factor
EBV
testicular germ cell tumors risk factor
Cryptorchidism
WAGR
Wilms tumour (a tumour of the kidneys)
Aniridia (absence of the coloured part of the eye, the iris), Genitourinary anomalies
mental Retardation
mutation in the adenomatous polyposis coli (APC gene)
autosomal dominant
multiple polyps in the colon together with tumors outside the colon
The extracolonic tumors may include osteomas of the skull, thyroid cancer, epidermoid cysts, fibromas
Gardner’s syndrome or familial colorectal polyposis
autosomal dominant
numerous adenomatous polyps form mainly in the epithelium of the large intestine
start out benign, malignant transformation into colon cancer occurs when they are left untreated
Familial adenomatous polyposis FAP
blueberry muffin rash
neuroblastoma
Chromosome 11p deletion syndrome
with sporadic aniridia
Wilms tumor
Chromosome 13q deletion syndrome
Retinoblastoma, sarcoma
Trisomy 21
Lymphocytic or nonlymphocytic leukemia,
especially megakaryocytic leukemia;
transient leukemoid reaction
Klinefelter syndrome (47,XXY)
Breast cancer, extragonadal germ cell tumors
Noonan syndrome
jmml
Xeroderma pigmentosum
Basal cell and squamous cell carcinomas;
melanoma
Fanconi anemia
Leukemia, myelodysplastic syndrome, liver
neoplasias, rare head and neck tumors, GI
and GU cancers
Bloom syndrome
Leukemia, lymphoma, and solid tumors
Ataxia-telangiectasia
Lymphoma, leukemia, less commonly central
nervous system and nonneural solid tumors
Dysplastic nevus syndrome
melanoma
Wiskott-Aldrich syndrome
Lymphoma, leukemia
X-linked immunodeficiency (Duncan
syndrome
Lymphoproliferative disorder
X-linked agammaglobulinemia (Bruton
disease)
Lymphoma, leukemia
Severe combined immunodeficiency
Leukemia, lymphoma
Neurofibromatosis 1
Neurofibroma, optic glioma, acoustic
neuroma, astrocytoma, meningioma,
pheochromocytoma, sarcoma
Neurofibromatosis 2
Bilateral acoustic neuromas, meningiomas
Tuberous sclerosis
Fibroangiomatous nevi, myocardial
rhabdomyoma
Li-Fraumeni syndrome p53 gene
Bone, soft tissue sarcoma, breast
Retinoblastoma also prone to
Sarcoma
Hemihypertrophy ± Beckwith syndrome
Wilms tumor, hepatoblastoma, adrenal
carcinoma
von Hippel-Landau disease
Hemangioblastoma of the cerebellum and
retina, pheochromocytoma, renal cancer
Multiple endocrine neoplasia syndrome, type 1 (Wermer syndrome)
Parathyroid, pancreatic islet, and pituitary
tumors
Multiple endocrine neoplasia syndrome, type 2A (Sipple syndrome)
Medullary carcinoma of the thyroid,
hyperparathyroidism, pheochromocytoma
Familial adenomatous polyposis
Colorectal, thyroid carcinoma, duodenal and
periampullar carcinomas; pediatric
hepatoblastoma
Familial juvenile polyposis
Colorectal carcinoma
Hereditary nonpolyposis colon cancer
Lynch syndrome, NHPCC
Colon cancer
Gardner syndrome
Adenocarcinoma of colon, skull and soft
tissue tumors
Peutz-Jeghers syndrome
Gastrointestinal carcinoma, ovarian neoplasia
Hemochromatosis
Hepatocellular carcinoma
Glycogen storage disease 1 (von Gierke
disease)
Hepatocellular carcinoma
Tyrosinemia, galactosemia
Hepatocellular carcinoma
Diamond-Blackfan anemia
AML, myelodysplastic syndrome, osteogenic
sarcoma
Shwachman-Diamond syndrome
AML, myelodysplasia
Congenital or cyclic neutropenia
Myelodysplastic syndrome
AML
cancer with diarrhea
neuroblastoma
ganglioneuroma
release of vasoactive intestinal peptide
if ALL develops in first twin during first year of life, risk for second twin for ALL is
> 70%
if ALL develops in first twin during 5-7yrs old, risk for second twin for ALL is
2x general population
ALL diagnosis BMA
> 25% lymphoblasts
traumatic initial lumbar tap for ALL assoc with
increased risk of CNS relapse
important predictive factors in ALL tx
- age of presentation (>1yr, <10yr)
- initial leukocyte count (50, 000)
- speed of response to therapy
chromosome abnormality with high risk of relapse
t (9,22)
t (4,11)
remission definition
<5% blasts in marrow
return of neutrophil and plt to normal after 4-5weeks